Jason Forbes, DO
Undersea and Hyperbaric Medicine · Springfield, MONPI 1841357357
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,125 of the $6,550 with a category attached, or 63.0%. Integra Lifesciences Corporation accounts for 77.4% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $3,800 and has fallen 94.6% since, to $206 in 2025.
Across 161 payments — averaging $40.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$5K
- Smith+Nephew$414
- KCI USA, Inc.$380
- Solventum Corporation$208
- Acera Surgical, Inc.$206
- Aroa Biosurgery Incorporated$71
- plus $200 from 8 others
What the payments were for
- Consulting fees$4,12563%
- Food & beverage$2,42537%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 62 | $5,071 |
| Smith+Nephew | 29 | $414 |
| KCI USA, Inc. | 24 | $380 |
| Solventum Corporation | 23 | $208 |
| Acera Surgical, Inc. | 8 | $206 |
| Aroa Biosurgery Incorporated | 5 | $71 |
| Organogenesis Inc. | 2 | $45 |
| Molnlycke Health Care US, LLC | 2 | $38 |
| Hartmann USA, Inc. | 1 | $29 |
| Hydrofera LLC | 1 | $27 |
| Next Science LLC | 1 | $25 |
| Medline Industries LP | 1 | $14 |
| Apria Healthcare LLC | 1 | $11 |
| Osiris Therapeutics Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMNIOEXCEL$3,188
- PRIMATRIX$3,188
- INTEGRA$1,875
- NEURAGEN$938
How this compares
Too few undersea and hyperbaric medicine providers in Missourito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 11 | $2,902 |
| Gentamicin Sulfate | 21 | $1,161 |
| Ketoconazole | 61 | $942 |
| Doxycycline Hyclate | 51 | $525 |
| Ciprofloxacin Hcl | 62 | $523 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 59 | $497 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 67 | $422 |
| Mupirocin | 39 | $403 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $236 |
| Triamcinolone Acetonide | 15 | $92 |
| Amoxicillin | 23 | $48 |
Paid to pharmacies, not to this prescriber.
Other undersea and hyperbaric medicine in Springfield
- Larry ChaseSpringfield$325
- Thad StephensKansas City$7K
- Craig GoldsteinKansas City$4K
- Valinda AllenSaint Louis$2K
- Gillian JonesSaint Joseph$2K
- Viktor BalladaSaint Louis$1K
- Jeffrey AlthoffKansas City$776
- Maxine TheriotPoplar Bluff$758
- David DickersonBlue Springs$728
- Ameet DeshmukhBlue Springs$526
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.